Skip to main content
Livermore
Livermore
ZHEN

Corvus Pharmaceuticals, Inc.

CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626971

No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Corvus Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+15 vs. Q1 2023
Shares held
19.5M
−1.30M (−6.3%) vs. Q1 2023
Total value
$44.6M
+$25.7M (+136.0%) vs. Q1 2023
New holders
22
11 more added
Sold out
7
6 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 52 institutions
Q1 2021: 49 institutionsQ2 2021: 50 institutionsQ3 2021: 61 institutionsQ4 2021: 62 institutionsQ1 2022: 57 institutionsQ2 2022: 47 institutionsQ3 2022: 48 institutionsQ4 2022: 42 institutionsQ1 2023: 37 institutionsQ2 2023: 52 institutionsQ3 2023: 52 institutionsQ4 2023: 48 institutionsQ1 2024: 47 institutionsQ2 2024: 47 institutionsQ3 2024: 62 institutionsQ4 2024: 86 institutionsQ1 2025: 88 institutionsQ2 2025: 92 institutionsQ3 2025: 103 institutionsQ4 2025: 124 institutionsQ1 2026: 164 institutionsQ2 2026: 173 institutions
Value heldQ2 2023: $44.6M
Q1 2021: $62.8MQ2 2021: $63.2MQ3 2021: $136.4MQ4 2021: $66.7MQ1 2022: $44.9MQ2 2022: $25.4MQ3 2022: $18.1MQ4 2022: $18.2MQ1 2023: $18.9MQ2 2023: $44.6MQ3 2023: $28.0MQ4 2023: $33.8MQ1 2024: $31.9MQ2 2024: $50.2MQ3 2024: $158.5MQ4 2024: $202.0MQ1 2025: $115.4MQ2 2025: $167.1MQ3 2025: $312.7MQ4 2025: $359.4MQ1 2026: $1.02BQ2 2026: $1.06B
Institutions holding CRVS and their total value by quarter
QuarterHoldersValue
Q2 2026173$1.06B
Q1 2026164$1.02B
Q4 2025124$359.4M
Q3 2025103$312.7M
Q2 202592$167.1M
Q1 202588$115.4M
Q4 202486$202.0M
Q3 202462$158.5M
Q2 202447$50.2M
Q1 202447$31.9M
Q4 202348$33.8M
Q3 202352$28.0M
Q2 202352$44.6M
Q1 202337$18.9M
Q4 202242$18.2M
Q3 202248$18.1M
Q2 202247$25.4M
Q1 202257$44.9M
Q4 202162$66.7M
Q3 202161$136.4M
Q2 202150$63.2M
Q1 202149$62.8M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q1 2023.

Institutions holding CRVS in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
OrbiMed Advisors LLC6,943,654$15.9M0.31%00.0%Unchanged
Adams Street Partners LLC3,275,616$7.50M1.96%00.0%Unchanged
Samlyn Capital, LLC2,105,930$4.82M0.08%+2,105,930New
BVF Inc1,370,947$3.14M0.09%00.0%Unchanged
Vanguard Group Inc1,301,225$2.98M0.00%+40,659+3.2%Added
BlackRock Inc.532,381$1.22M0.00%+39,159+7.9%Added
Artal Group S.A.500,000$1.15M0.04%00.0%Unchanged
Renaissance Technologies LLC489,673$1.12M0.00%−16,359−3.2%Reduced
Geode Capital Management, LLC342,079$783.4K0.00%+44,279+14.9%Added
Marshall Wace, LLP299,140$685.0K0.00%+299,140New
Two Sigma Investments, LP254,254$582.2K0.00%+50,207+24.6%Added
Towerview LLC205,000$469.4K0.31%+205,000New
CHI Advisors LLC200,000$458.0K0.14%−2,139,402−91.5%Reduced
Susquehanna International Group, LLP195,252$447.1K0.00%+184,809+1,769.7%Added
Two Sigma Advisers, LP178,800$409.5K0.00%−8,500−4.5%Reduced
Morgan Stanley139,635$319.8K0.00%+39,476+39.4%Added
State Street Corp138,403$316.9K0.00%+25,800+22.9%Added
Bridgeway Capital Management, LLC109,300$250.3K0.01%−50,000−31.4%Reduced
MYDA Advisors LLC100,000$229.0K0.09%+100,000New
Cornercap Investment Counsel Inc97,248$222.7K0.04%+97,248New
Goldman Sachs Group Inc94,311$216.0K0.00%+94,311New
Connor, Clark & Lunn Investment Management Ltd.84,368$193.2K0.00%+84,368New
Northern Trust Corp65,017$148.9K0.00%+3,349+5.4%Added
Jackson Square Capital, LLC63,773$146.0K0.06%00.0%Unchanged
Dimensional Fund Advisors LP58,112$133.1K0.00%+58,112New
Acadian Asset Management LLC58,069$132.0K0.00%−73,702−55.9%Reduced
Hikari Power Ltd49,959$114.0K0.01%00.0%Unchanged
Jane Street Group, LLC35,118$80.4K0.00%+35,118New
Virtu Financial LLC25,542$58.0K0.00%+6,188+32.0%Added
Bank of New York Mellon Corp21,219$48.6K0.00%+21,219New
Tower Research Capital LLC (TRC)20,543$47.0K0.00%+7,946+63.1%Added
Commerce Bank20,000$45.8K0.00%00.0%Unchanged
Squarepoint Ops LLC17,082$39.1K0.00%+17,082New
Charles Schwab Investment Management Inc15,668$35.9K0.00%+15,668New
Cubist Systematic Strategies, LLC15,552$35.6K0.00%+15,552New
Tucker Asset Management LLC12,871$29.5K0.01%+12,871New
Simplex Trading, LLC11,529$26.0K0.00%+11,529New
Invesco Ltd.10,945$25.1K0.00%+10,945New
Difesa Capital Management, LP10,000$22.9K0.06%+10,000New
UBS Group AG6,700$15.3K0.00%−4,314−39.2%Reduced
Bank of America Corp5,079$11.6K0.00%+5,079New
Whittier Trust Co of Nevada Inc4,200$9.58K0.00%00.0%Unchanged
Northwest Capital Management Inc3,397$7.78K0.00%+3,397New
JPMorgan Chase & Co1,201$2.75K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.1,100$2.52K0.00%00.0%Unchanged
Natixis800$1.83K0.00%+800New
Rhumbline Advisers791$1.81K0.00%+791New
Wells Fargo & Company248$5680.00%+10+4.2%Added
NewSquare Capital LLC220$5040.00%+220New
Parallel Advisors, LLC20$460.00%00.0%Unchanged
IFP Advisors, Inc24$190.00%00.0%Unchanged
Barclays PLC1$20.00%00.0%Unchanged
Millennium Management LLC0$00.00%−2,029,423−100.0%Sold out
Discovery Capital Management, LLC0$00.00%−548,727−100.0%Sold out
LMR Partners LLP0$00.00%−30,000−100.0%Sold out
Baader Bank INC0$00.00%−24,911−100.0%Sold out
Mercer Global Advisors Inc0$00.00%−10,550−100.0%Sold out
Envestnet Asset Management Inc0$00.00%−10,500−100.0%Sold out
TCI Wealth Advisors, Inc.0$00.00%−500−100.0%Sold out